Skip to main content
. 2019 Aug 29;9:12561. doi: 10.1038/s41598-019-49026-y

Table 4.

Cox multivariate proportional hazard analysis according to GAP stage.

Variables GAP stage I GAP stage II/III
HR 95% CI P value HR 95% CI P value
Lung cancer stage 0.001 0.002
  Stage I 1.000 1.000
  Stage II 1.489 0.722–3.072 0.281 0.183 0.023–1.455 0.108
  Stage III 1.508 0.715–3.179 0.281 5.384 0.520–55.729 0.158
  Stage IV 7.775 2.593–23.307 <0.001 35.94 3.606–358.215 0.002
ECOG 0.077 0.007
  ECOG 0 and 1 1.000 1.000
  ECOG 2 1.134 0.471–2.732 0.779 3.71 1.436–9.587 0.007
  ECOG 3 and 4 3.037 1.152–8.010 0.025 4.711 1.558–14.240 0.006
Primary treatment 0.005 0.377
  Conservative care 1.000 1.000
  Operation 0.233 0.094–0.574 0.002 2.118 0.261–17.207 0.482
  Chemotherapy 0.613 0.210–1.787 0.370 0.818 0.296–2.265 0.700
  Radiotherapy 0.421 0.115–1.541 0.191 0.323 0.077–0.077 0.123
Total amount of cigarettes smoked in a lifetime (PYs) 0.993 0.982–1.004 0.189 1.016 1.002–1.031 0.031

Abbreviations: HR = Hazard ratio, GAP = gender (G), age (A), and two physiology variables (P) (FVC and DLco)) stage system; PYs = pack-years; ECOG = Eastern Cooperative Oncology Group.

*Adjusted for lung cancer clinical stage, ECOG, primary treatment, and smoking amount.